Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loading-dose clopidogrel versus prasugrel before elective PCI
IRCT201408069768N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of clopidogrel and prasugrel in coronary arteriosclerosis and angina pectoris (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Incidence of myocardial injury and Incidence of subsequent myocardial infarction. Started Jan 2013; status: completed.
02
Drugs
clopidogrelprasugrel
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on IRCT201408069768N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201408069768N3.